Registration Dossier

Diss Factsheets

Administrative data

Endpoint:
short-term repeated dose toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2020-2021
Reliability:
1 (reliable without restriction)
Justification for type of information:
The dossier for the registration substance is being submitted February 2021 due to a Givaudan client request in order to ensure compliance for the client as a downstream user.
This study began in July 2020 and an update of the dossier will be done once the final report with results is finalised in 2021. Please see attached statement of work between Givaudan International S.A. and Charles River Laboratories Ashland, LLC.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2021

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
Version / remarks:
2016
GLP compliance:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
ethyl 2-acetyl-4-methyltridec-2-enoate
EC Number:
816-455-0
Cas Number:
960253-23-0
Molecular formula:
C18H32O3
IUPAC Name:
ethyl 2-acetyl-4-methyltridec-2-enoate
Test material form:
liquid

Results and discussion

Effect levels

Remarks on result:
other: awaiting test results

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion

Categories Display